Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Igor Age Kos

Showing results (1-10 of 22) with videos related to

Pageof 3
Sort By:
Current Pharmaceutical Design|December 1, 2017
The Experience with Biosimilars of Infliximab in Rheumatic DiseasesValderilio Feijo Azevedo, Igor Age Kos, Leonardo Ariello
Cancers|June 24, 2022
Management of Extranodal Marginal Zone Lymphoma: Present and Upcoming PerspectivesDominic Kaddu-Mulindwa, Lorenz Thurner, Konstantinos Christofyllakis, et al.
Frontiers in Medicine|March 30, 2026
Editorial: Novel therapies and unexpected challenges: overcoming immune-mediated toxicities in modern oncologyIgor Age Kos, Salvatore Fiorenza, Michel Michels de Oliveira, et al.
Drugs in Context|October 11, 2018
The biosimilars journey: current status and ongoing challengesIgor Age Kos, Valderílio Feijó Azevedo, Daniel Egg Neto, et al.
Diagnostics (Basel, Switzerland)|December 24, 2021
Advances in Lymphoma Molecular DiagnosticsIgor Age Kos, Lorenz Thurner, Joerg Thomas Bittenbring, et al.
Journal of Geriatric Oncology|May 7, 2022
Biomarker guided treatment in oncogene-driven advanced non-small cell lung cancer in older adults: A Young International Society of Geriatric Oncology reportKonstantinos Christofyllakis, Ana Raquel Monteiro, Onur Cetin, et al.
Einstein (Sao Paulo, Brazil)|September 20, 2018
Partnership for productive development of biosimilar products: perspectives of access to biological products in the Brazilian marketMorton Aaron Scheinberg, Paulo Antonio Oldani Felix, Igor Age Kos, et al.
Advances in Rheumatology (London, England)|August 9, 2019
Benzbromarone in the treatment of goutValderilio Feijó Azevedo, Igor Age Kos, Ana Beatriz Vargas-Santos, et al.
Nutrients|August 26, 2023
Vitamin D Enhances Immune Effector Pathways of NK Cells Thus Providing a Mechanistic Explanation for the Increased Effectiveness of Therapeutic Monoclonal AntibodiesKonstantinos Christofyllakis, Frank Neumann, Moritz Bewarder, et al.
Journal of Clinical Rheumatology : Practical Reports on Rheumatic & Musculoskeletal Diseases|October 2, 2018
Report on the Second PANLAR Review Course in Rheumatology: Biosimilars UpdateCarlos Vinicius Caballero-Uribe, Valderilio Feijó Azevedo, Enrique Roberto Soriano, et al.
Pageof 3

Showing results (1-10 of 22) with videos related to

Sort By:
Pageof 3
Current Pharmaceutical Design|December 1, 2017
The Experience with Biosimilars of Infliximab in Rheumatic DiseasesValderilio Feijo Azevedo, Igor Age Kos, Leonardo Ariello
Cancers|June 24, 2022
Management of Extranodal Marginal Zone Lymphoma: Present and Upcoming PerspectivesDominic Kaddu-Mulindwa, Lorenz Thurner, Konstantinos Christofyllakis, et al.
Frontiers in Medicine|March 30, 2026
Editorial: Novel therapies and unexpected challenges: overcoming immune-mediated toxicities in modern oncologyIgor Age Kos, Salvatore Fiorenza, Michel Michels de Oliveira, et al.
Drugs in Context|October 11, 2018
The biosimilars journey: current status and ongoing challengesIgor Age Kos, Valderílio Feijó Azevedo, Daniel Egg Neto, et al.
Diagnostics (Basel, Switzerland)|December 24, 2021
Advances in Lymphoma Molecular DiagnosticsIgor Age Kos, Lorenz Thurner, Joerg Thomas Bittenbring, et al.
Journal of Geriatric Oncology|May 7, 2022
Biomarker guided treatment in oncogene-driven advanced non-small cell lung cancer in older adults: A Young International Society of Geriatric Oncology reportKonstantinos Christofyllakis, Ana Raquel Monteiro, Onur Cetin, et al.
Einstein (Sao Paulo, Brazil)|September 20, 2018
Partnership for productive development of biosimilar products: perspectives of access to biological products in the Brazilian marketMorton Aaron Scheinberg, Paulo Antonio Oldani Felix, Igor Age Kos, et al.
Advances in Rheumatology (London, England)|August 9, 2019
Benzbromarone in the treatment of goutValderilio Feijó Azevedo, Igor Age Kos, Ana Beatriz Vargas-Santos, et al.
Nutrients|August 26, 2023
Vitamin D Enhances Immune Effector Pathways of NK Cells Thus Providing a Mechanistic Explanation for the Increased Effectiveness of Therapeutic Monoclonal AntibodiesKonstantinos Christofyllakis, Frank Neumann, Moritz Bewarder, et al.
Journal of Clinical Rheumatology : Practical Reports on Rheumatic & Musculoskeletal Diseases|October 2, 2018
Report on the Second PANLAR Review Course in Rheumatology: Biosimilars UpdateCarlos Vinicius Caballero-Uribe, Valderilio Feijó Azevedo, Enrique Roberto Soriano, et al.
Pageof 3